Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect Conference

Rhea-AI Summary

Osmotica Pharmaceuticals (Nasdaq: OSMT) announced that CEO Brian Markison, COO James Schaub, and CFO Andrew Einhorn will present at the H.C. Wainwright Bioconnect Conference on January 10, 2022, at 7:00 AM ET. The presentation will be available for on-demand viewing for 30 days via the provided webcast link and the Company’s website. Osmotica focuses on developing pharmaceutical products for underserved markets, with additional operations in Hungary.

News Market Reaction – OSMT

+3.88%

+3.88% Session move

In the trading session that priced this news, OSMT gained 3.88%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BRIDGEWATER, N.J., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, announced today that Brian Markison, Chief Executive Officer, James “JD” Schaub, Chief Operating Officer, and Andrew Einhorn, Chief Financial Officer, will present virtually at the H.C. Wainwright Bioconnect Conference as follows:

Date:	Monday, January 10, 2022
On Demand Time:	7:00AM ET
Webcast:	https://journey.ct.events/view/b39a70c0-7058-4a1f-ba97-e18b13918fc7

The presentation will be webcast on-demand and available for 30 days thereafter using the link provided above and via the Company’s website at www.osmotica.com under the “Investor & News” section.

About Osmotica Pharmaceuticals plc
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) is a specialty pharmaceutical company focused on the development and commercialization of products that target markets with underserved patient populations. RVL Pharmaceuticals, Inc. is the Company’s ophthalmic subsidiary supporting UPNEEQ^®.

Osmotica has operations in the United States and Hungary.

Investor and Media Relations for Osmotica Pharmaceuticals plc
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

FAQ

When will Osmotica Pharmaceuticals present at the H.C. Wainwright Bioconnect Conference?

Osmotica Pharmaceuticals will present on January 10, 2022, at 7:00 AM ET.

Where can I watch the Osmotica Pharmaceuticals conference presentation?

The presentation can be watched on-demand at the provided link for 30 days following the event.

Who are the key executives presenting for Osmotica Pharmaceuticals?

The key executives presenting are CEO Brian Markison, COO James Schaub, and CFO Andrew Einhorn.

What is the focus of Osmotica Pharmaceuticals?

Osmotica Pharmaceuticals focuses on developing products for underserved patient populations.

What is the stock symbol for Osmotica Pharmaceuticals?

The stock symbol for Osmotica Pharmaceuticals is OSMT.